TEL AVIV (MarketWatch) -- Israeli stocks slipped on Thursday, as banks were weak and investors awaited Teva Pharmaceutical's update.
The Tel Aviv Stock Exchange's benchmark TA-25 Index closed down 0.30% to 1166.23, while the TA-100 Index /quotes/comstock/!ta100 (XX:TA100 1,098, +0.11, +0.01%) slipped 0.39% to 1094.04.
The Tel-Tech 15 Index of top technology issues gave up 0.72% to 244.21.
Teva Pharmaceutical shares /quotes/comstock/15*!teva/quotes/nls/teva (TEVA 56.84, -0.36, -0.63%) edged down 0.1%.
Goldman Sachs reiterated a buy rating on Teva before the drugmaker's Webcast meeting with analysts to provide an outlook. The firm's analysts raised their 12-month price target on the stock to $65 from $61.
Goldman expects the company to address several issues, including potential acquisitions, it strategy regarding Copaxone, its flagship multiple-sclerosis medication, and growth prospects for 2011.
